Considering that PGR (the PR-encoding gene) is a direct ER target gene (39), and FOXA1 is a critical pioneer factor for ER (40), it can be hypothesized that Sox2 altered ER transcriptional activity in FMCs of the present study as it does in breast cancers (41). The gene discussed is PGR; the disease is breast cancer.